Global Implantable Drug-Eluting Devices Market Research Report 2021

Implantable drug-eluting devices offer several unique advantages over conventional oral or parenteral drug delivery methods.

The global Implantable Drug-Eluting Devices market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Implantable Drug-Eluting Devices volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Implantable Drug-Eluting Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Implantable Drug-Eluting Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Implantable Drug Infusion Pumps
Intraocular Drug-Eluting Devices
Contraceptive Drug-Eluting Devices
Drug-Eluting Stents
Others

Segment by Application
Diabetes
Contraception
HIV/AIDS Prevention
Chronic Pain Management
Cardiovascular
Ophthalmology
Oncology
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Pfizer
Medtronic
Merck
Bayer AG
Johnson & Johnson
Abbott
Surmodics
Boston Scientific Corporation
Titan Pharmaceuticals, Inc.
BIOTRONIK
Allergan
Bausch & Lomb
REVA Medical
MicroPort Medical